Large animal models of huntington's disease: What we have learned and where we need to go next

David Howland, Zdenka Ellederova, Neil Aronin, Deborah Fernau, Jill Gallagher, Amanda Taylor, Jon Hennebold, Alison R. Weiss, Heather Gray-Edwards, Jodi McBride

    Research output: Contribution to journalReview articlepeer-review

    14 Scopus citations


    Genetically modified rodent models of Huntington's disease (HD) have been especially valuable to our understanding of HD pathology and the mechanisms by which the mutant HTT gene alters physiology. However, due to inherent differences in genetics, neuroanatomy, neurocircuitry and neurophysiology, animal models do not always faithfully or fully recapitulate human disease features or adequately predict a clinical response to treatment. Therefore, conducting translational studies of candidate HD therapeutics only in a single species (i.e. mouse disease models) may not be sufficient. Large animal models of HD have been shown to be valuable to the HD research community and the expectation is that the need for translational studies that span rodent and large animal models will grow. Here, we review the large animal models of HD that have been created to date, with specific commentary on differences between the models, the strengths and disadvantages of each, and how we can advance useful models to study disease pathophysiology, biomarker development and evaluation of promising therapeutics.

    Original languageEnglish (US)
    Pages (from-to)201-216
    Number of pages16
    JournalJournal of Huntington's disease
    Issue number3
    StatePublished - 2020


    • Minipigs
    • nonhuman primates
    • sheep
    • therapeutics

    ASJC Scopus subject areas

    • Clinical Neurology
    • Cellular and Molecular Neuroscience


    Dive into the research topics of 'Large animal models of huntington's disease: What we have learned and where we need to go next'. Together they form a unique fingerprint.

    Cite this